Leading Chinese doctors announced that the first coronavirus clinical trial of the HIV-treatment drug Lopinavir has finished at a conference in Beijing on Wednesday.
“The good news is that the first trial [from the] Lopinavir clinical trial is finished. The Chinese doctors will share the new results with WHO and the international society as soon as possible,” said Vice President of China-Japan Friendship Hospital, Cao Bin.
Dr Li Haichao, who works with Cao on clinical tests at the COVID-19 virus epicentre in Wuhan, suggested oxygen therapy to be an efficient treatment for patients whose conditions deteriorate into severe pneumonia and Acute Respiratory Distress Syndrome (ARDS).
Du Bin, Director of Medical ICU at Peking Union Medical College Hospital, suggested that the only way to “fight against the plague” was if everyone did their job, and urged the government to “to educate the general public about the disease and how to prevent [the disease]. And to coordinate and organise all the resources, including human resources and other equipment.”
According to the latest reports by the European Centre for Disease Prevention and Control (ECDC), at least 94,000 people have been infected by the COVID-19 so far and over 3,200 people have died. There are currently 80,270 cases confirmed on China’s mainland.